Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 February 2022 | Story Lacea Loader

From 24 February 2022 – as an interim solution to the challenges experienced with the disruption of classes on the University of the Free State (UFS) Bloemfontein Campus during the week of 21 February 2022 – the academic programme will continue in a differentiated and flexible online mode in some modules within faculties.

Face-to-face classes will continue in those modules where online teaching is not possible at this stage. Students will be informed by their respective faculties as to which modules will be moving online, and which will remain face to face.

This is a temporary measure to enable the campus to return to stability. The arrangement is estimated to continue for two to three weeks at the most, after which the academic programme will return to the approved teaching plans for 2022.

As an additional measure and to mitigate the challenges of remote off-campus internet access, 10 GB of data is provided free of charge through Global Protect to all registered students for the next month. This will enable students to link to learning resources off campus at no cost. The use of social media is, however, not included in the 10 GB.

Enquiries regarding GlobalProtect can be directed to the ICT Services Call Centre at +27 51 401 9111 (option 4).

Computer laboratories on the campus will remain available to vaccinated students whose modules will be moving online.

Issued by:
Lacea Loader
Director: Communication and Marketing
University of the Free State
loaderl@ufs.ac.za

23 February 2022

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept